DAY ONE BIOPHARMACEUTICALS INC
(NASDAQ: DAWN)
Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in Brisbane, CA.
16.610
+0.560
(+3.49%)
Range
16.130 - 16.730
(3.72%)
Open
-
Previous Close
16.050
Bid Price
12.530
Bid Volume
9
Ask Price
13.470
Ask Volume
8
Volume
331,986
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis